Do quality of life and work productivity change in early axial spondyloarthritis and non-axial spondyloarthritis patients after 2 years?

Author:

Bento da Silva Ana123ORCID,Ramiro Sofia14ORCID,Boel Anne15,van Lunteren Miranda1ORCID,Marques Mary Lucy16ORCID,van de Sande Marleen7,Fongen Camilla8,Exarchou Sofia9ORCID,Ramonda Roberta10ORCID,van der Heijde Désirée1ORCID,van Gaalen Floris1ORCID

Affiliation:

1. Department of Rheumatology, Leiden University Medical Center , Leiden, The Netherlands

2. Department of Rheumatology, West Lisbon Hospital Center , Lisbon, Portugal

3. iNOVA4Health , Lisbon, Portugal

4. Department of Rheumatology, Zuyderland Medical Center , Heerlen, The Netherlands

5. UCB Pharma B.V. , Breda, The Netherlands

6. Department of Rheumatology, Coimbra University Hospital Center , Coimbra, Portugal

7. Department of Rheumatology and Clinical Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Center , Amsterdam, the Netherlands

8. Division of Rheumatology and Research, Diakonhjemmet Hospital , Oslo, Norway

9. Department of Clinical Sciences Malmö, Rheumatology, Lund University , Sweden , Malmö

10. Rheumatology Unit, Department of Medicine-DIMED, University of Padova , Padova, Italy

Abstract

Abstract Objective The objective of this study was to compare health-related quality of life (HRQoL) and work productivity in axial SpA (axSpA) and non-axSpA patients with chronic back pain of <2 years. Methods Baseline and 2-year data for patients included in the SPondyloArthritis Caught Early cohort were analysed. HRQoL was assessed by the physical (PCS) and mental component summary (MCS) scores of the 36-Item Short-Form Health Survey, and presenteeism, absenteeism, work productivity loss (WPL) and activity impairment (AI) by the Work Productivity and Activity Impairment questionnaire. Linear or zero-inflated negative binomial regression was conducted to compare 2-year outcomes between groups (axSpA and non-axSpA), adjusting for the baseline value, sex, age and use of NSAIDs. Results There were 265 axSpA and 108 non-axSpA patients: males 52% vs 26%, mean age 29 vs 31 years, respectively. At baseline, non-axSpA patients showed worse PCS (mean 28.6 axSpA vs 26.6 non-axSpA), presenteeism (31.1% vs 37.3%), absenteeism (8.2% vs 10.3%), WPL (34.7% vs 44.1%) and AI (39.6% vs 48.5%). MCS was not impaired in either group. After 2 years, PCS, presenteeism, WPL and AI significantly improved in both groups; absenteeism only improved in axSpA. In multivariable analysis, axSpA (vs non-axSpA) was associated with 22% less WPL [incidence rate ratio (95% CI): 0.78 (0.62; 0.98)] and 18% less AI [0.82 (0.69; 0.97)]. Conclusion HRQoL and work productivity are more impaired in non-axSpA (vs axSpA) at baseline and also after 2 years. Although most outcomes improve in both groups, axSpA is associated with larger reductions in WPL and AI.

Funder

Assessment of SpondyloArthritis international Society

Publisher

Oxford University Press (OUP)

Reference41 articles.

1. Ankylosing spondylitis;Braun;Lancet,2007

2. Diagnostic delay in axial spondyloarthritis: a systematic review and meta-analysis;Zhao;Rheumatology,2021

3. Axial spondyloarthritis;Sieper;Lancet,2017

4. The burden of ankylosing spondylitis;Boonen;J Rheumatol Suppl,2006

5. Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy;Davis;Arthritis Rheum,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3